Neok002 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

22 results for “Neok002”

Trials

View all 14 →

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

155 participants · First posted May 28, 2026

The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis

260 participants · First posted Dec 9, 2014

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

34 participants · First posted Nov 24, 2015

Drugs

Neo2001

SJ-Neo006

News

Neok Bio Emerges with $75M to Develop Dual-Targeting ADCs for Cancer Treatment

ABL Bio and NEOK Bio Advance First-in-Class Bispecific ADC ABL206 to Phase 1 Clinical Trial

China's NMPA Accepts Vyluma's NVK002 Drug Application for Pediatric Myopia

Page 1 of 3